2026 Annual Meeting | C32 - Treatment of Pediatric Multiple Sclerosis in the Current Era

��ɫ��

2026 Annual Meeting | C32 - Treatment of Pediatric Multiple Sclerosis in the Current Era

Date Saturday 04/18/26

Time 02:30 PM - 04:30 PM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Leslie A. Benson, MD

Topic(s) Multiple Sclerosis

Learning Objectives Participants should become familiar with the spectrum of interventions used in the care of pediatric onset MS including clinic resources, pharmacologic and non-pharmacologic therapies and why they are utilized. The impact of interventions and interplay with social determinants of health in pediatric MS management will be discussed.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
02:30 PM - 02:35 PM CDT	Introduction	Introduction Leslie A. Benson, MD
02:35 PM - 03:10 PM CDT	Speaker	Non-pharmacologic Treatment in Pediatric MS Elizabeth V. Wilson, MD
03:10 PM - 03:45 PM CDT	Speaker	Disease-modifying Therapy in Pediatric MS Leslie A. Benson, MD
03:45 PM - 04:20 PM CDT	Speaker	Prognosis and Outcomes in the Current Era Vaishnavi L. Vaidyanathan, MD
04:20 PM - 04:30 PM CDT	Q&A	Questions and Answers Leslie A. Benson, MD, Elizabeth V. Wilson, MD, Vaishnavi L. Vaidyanathan, MD

Faculty Disclosures
Elizabeth V. Wilson, MD	Dr. Wilson has received research support from Department of Defense. Dr. Wilson has received research support from NIH/NINDS.
Leslie A. Benson, MD	The institution of Dr. Benson has received research support from ROHHAD Fight, Inc. The institution of Dr. Benson has received research support from NIH. The institution of Dr. Benson has received research support from Roche/Genentech. Dr. Benson has received personal compensation in the range of $0-$499 for serving as a consultant with MA Department of public health. Dr. Benson has received personal compensation in the range of $10,000-$49,999 for serving as a consultant with National vaccine injury compensation program.
Vaishnavi L. Vaidyanathan, MD	Dr. Vaidyanathan has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��